You need to be logged in to view this video

Angiogenesis in the Brain to Reverse Parkinson's Disease, Alzheimer's Disease and More!

Released on Monday, May 13, 2019•BIOTECH

Share
Facebook Twitter LinkedIn SMS

Angiogenesis, or the re-growth of new blood vessels in damaged tissues, is an important regenerative process in our bodies. Learn how potent inducers of this process are showing promise in treating neurodegenerative diseases, such as Parkinson's disease.

Jack Jacobs

Zhittya Genesis Medicine, Inc., President and Chief Scientific Officer

Dr. Jack Jacobs has been involved in the healthcare industry for over 25 years and has extensive expertise in supervising drug manufacturing operations, as well as the design and implementation of preclinical animal trials and US FDA-authorized clinical trials. He started a new department of biological chemistry at Merck and for 15 years worked with Mr. Daniel Montano as cardiovascular biotherapeutics' chief scientific officer. Dr. Jacobs oversaw FDA-authorized clinical trials in which FGF-1 was tested in a number of medical indications, including coronary artery disease, diabetic foot ulcers, and peripheral artery disease. He also oversaw the manufacturing of clinical lots of FGF-1 that were used in those clinical studies. Dr. Jacobs received a BS degree from Davidson College and a PhD in molecular biology from Washington University, St. Louis.